MedPageToday -- The FDA has approved everolimus (Afinitor) for treatment of benign brain tumors associated with a rare genetic condition in patients who are not candidates for surgical resection.
MedPageToday -- The FDA has approved everolimus (Afinitor) for treatment of benign brain tumors associated with a rare genetic condition in patients who are not candidates for surgical resection.